DK2025685T3 - Monoklonale antistoffer mod BETA3-integriner. - Google Patents

Monoklonale antistoffer mod BETA3-integriner.

Info

Publication number
DK2025685T3
DK2025685T3 DK08153880.3T DK08153880T DK2025685T3 DK 2025685 T3 DK2025685 T3 DK 2025685T3 DK 08153880 T DK08153880 T DK 08153880T DK 2025685 T3 DK2025685 T3 DK 2025685T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
antibodies against
beta3 integrins
integrins
against beta3
Prior art date
Application number
DK08153880.3T
Other languages
English (en)
Inventor
Heyu Ni
Guangheng Zhu
Original Assignee
Canadian Blood Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Blood Services filed Critical Canadian Blood Services
Application granted granted Critical
Publication of DK2025685T3 publication Critical patent/DK2025685T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK08153880.3T 2007-08-15 2008-03-31 Monoklonale antistoffer mod BETA3-integriner. DK2025685T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95595707P 2007-08-15 2007-08-15

Publications (1)

Publication Number Publication Date
DK2025685T3 true DK2025685T3 (da) 2013-09-02

Family

ID=39577844

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08153880.3T DK2025685T3 (da) 2007-08-15 2008-03-31 Monoklonale antistoffer mod BETA3-integriner.

Country Status (4)

Country Link
US (1) US7731966B2 (da)
EP (1) EP2025685B1 (da)
CA (1) CA2628900C (da)
DK (1) DK2025685T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5989893B2 (ja) * 2012-04-18 2016-09-07 レミン ワン， インテグリンβサブユニットの静脈血栓塞栓の診断における使用
US9574001B2 (en) * 2012-08-02 2017-02-21 New York University Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
JP2015533117A (ja) * 2012-08-31 2015-11-19 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル インスリン様成長因子１（ｉｇｆ−１）を増強または阻害するためのモノクローナル抗体
US10364288B2 (en) 2013-05-24 2019-07-30 Biogen Ma Inc. Anti-GPIIB/IIIA antibodies or uses thereof
DK3126391T3 (da) 2014-03-31 2019-11-25 Univ I Tromsoe Norges Arktiske Univ ANTISTOFFER MOD HPA-1a
MA40835A (fr) 2014-10-23 2017-08-29 Biogen Ma Inc Anticorps anti-gpiib/iiia et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
BR0014222A (pt) * 1999-09-23 2003-02-25 Scripps Research Inst Método e composições para inibir a formação de adesão
CN1230447C (zh) 2002-07-17 2005-12-07 阮长耿 识别血小板膜糖蛋白的单克隆抗体及其在抗血栓治疗中的应用

Also Published As

Publication number Publication date
US20090047290A1 (en) 2009-02-19
EP2025685B1 (en) 2013-06-19
CA2628900A1 (en) 2009-02-15
US7731966B2 (en) 2010-06-08
CA2628900C (en) 2014-07-08
EP2025685A1 (en) 2009-02-18

Similar Documents

Publication Publication Date Title
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
DK2225280T3 (da) Bivalente, bispecifikke antistoffer
BRPI0821375A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0821405A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0807991A2 (pt) Anticorpos anti-il-23r elaborados.
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
BRPI0820073A2 (pt) Anticorpos anti-axl
SMT201700083B (it) Anticorpi monoclonali
DK2059536T3 (da) Optimerede antistoffer, der er rettet mod cd19
BRPI1014474A2 (pt) anticorpos biespecíficos anti-erbb-1/anti-c-met.
NO344963B1 (no) Humanisert antistoff
DK3401334T3 (da) Monoklonale antistoffer mod claudin-18 til cancerbehandling
DK2167128T3 (da) Fremstillede anti-alfa-v-integrin hybrid-antistoffer
BRPI0923231A2 (pt) anticorpo anti-cmet.
BRPI0907237A2 (pt) Anticorpo anti-cldn6
CL2008001011S1 (es) Recipiente.
BRPI1010297A2 (pt) anticorpos biespecíficos trivalentes.
BRPI0814111A2 (pt) Anticorpo monoclonal citotóxico anticâncer
DK2059533T3 (da) Multispecifikke antistoffer
FI20075278A0 (fi) Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
CL2007002246S1 (es) Contenedor.
BRPI0813245A2 (pt) Escova de dentes.
BRPI0817427A2 (pt) Anticorpo anti-bst2
CL2007003665S1 (es) Envase.